Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17540669rdf:typepubmed:Citationlld:pubmed
pubmed-article:17540669lifeskim:mentionsumls-concept:C0027573lld:lifeskim
pubmed-article:17540669lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:17540669lifeskim:mentionsumls-concept:C0007732lld:lifeskim
pubmed-article:17540669lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:17540669lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:17540669lifeskim:mentionsumls-concept:C0135892lld:lifeskim
pubmed-article:17540669pubmed:issue1lld:pubmed
pubmed-article:17540669pubmed:dateCreated2007-6-19lld:pubmed
pubmed-article:17540669pubmed:abstractTextIn Neisseria gonorrhoeae, the mosaic structure of penicillin-binding protein 2 (PBP 2), composed of fragments of PBP 2 from Neisseria cinerea and Neisseria perflava, was significantly associated with decreased susceptibility to cephalosporins, particularly oral cephalosporins. The aim of this study was to determine the affinity of mosaic PBP 2 for cephalosporins in N. gonorrhoeae.lld:pubmed
pubmed-article:17540669pubmed:languageenglld:pubmed
pubmed-article:17540669pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:citationSubsetIMlld:pubmed
pubmed-article:17540669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540669pubmed:statusMEDLINElld:pubmed
pubmed-article:17540669pubmed:monthJullld:pubmed
pubmed-article:17540669pubmed:issn0305-7453lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:DeguchiTakash...lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:IshikoHiroaki...lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:Matsushima-Ni...lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:KozawaOsamuOlld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:HayashiAkioAlld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:YasudaMitsuru...lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:ShimadzuMitsu...lld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:OchiaiSusumuSlld:pubmed
pubmed-article:17540669pubmed:authorpubmed-author:SekiguchiSato...lld:pubmed
pubmed-article:17540669pubmed:issnTypePrintlld:pubmed
pubmed-article:17540669pubmed:volume60lld:pubmed
pubmed-article:17540669pubmed:ownerNLMlld:pubmed
pubmed-article:17540669pubmed:authorsCompleteYlld:pubmed
pubmed-article:17540669pubmed:pagination54-60lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:meshHeadingpubmed-meshheading:17540669...lld:pubmed
pubmed-article:17540669pubmed:year2007lld:pubmed
pubmed-article:17540669pubmed:articleTitleDecreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae.lld:pubmed
pubmed-article:17540669pubmed:affiliationResearch and Development Department, Mitsubishi Kagaku Bio-Clinical Laboratories, Inc., 3-30-1 Shimura, Itabashi-Ku, Tokyo 174-8555, Japan. ochiai.susumu@mg.medience.co.jplld:pubmed
pubmed-article:17540669pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540669lld:pubmed